ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 269 filers reported holding ARGENX SE in Q4 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $334,388 | -77.6% | 858 | -78.6% | 0.06% | -78.4% |
| Q1 2023 | $1,490,693 | +9.5% | 4,001 | +11.3% | 0.28% | -14.7% |
| Q4 2022 | $1,361,894 | -12.9% | 3,595 | -18.8% | 0.33% | -8.4% |
| Q3 2022 | $1,564,000 | +189.1% | 4,429 | +210.2% | 0.36% | +143.8% |
| Q2 2022 | $541,000 | -26.6% | 1,428 | -38.9% | 0.15% | -26.6% |
| Q1 2022 | $737,000 | +17.0% | 2,337 | +29.8% | 0.20% | -7.9% |
| Q4 2021 | $630,000 | +60.3% | 1,800 | +38.5% | 0.22% | +68.8% |
| Q3 2021 | $393,000 | – | 1,300 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |